FAKTOR-OPTIONSSCHEIN - BRISTOL-MYERS SQUIBB | Market Closed - Deutsche Boerse AG 01:19:43 15/06/2024 am IST | ||
| 14.69 EUR | +1.31% |
|
| Current month | -9.99% | ||
| 1 month | +51.29% |
Comparison chart between the derivative product and it's underlying value
End-of-day quotes
Latest news about BRISTOL-MYERS SQUIBB COMPANY
More news
| Date | Price | Change |
|---|---|---|
| 14/24/14 | 14.69 | +1.31% |
| 13/24/13 | 14.5 | +16.09% |
| 12/24/12 | 12.49 | +6.03% |
| 11/24/11 | 11.78 | -7.75% |
| 10/24/10 | 12.77 | -13.72% |
Delayed Quote Deutsche Boerse AG
Last update June 15, 2024 at 01:19 am IST
More quotesStatic data
| Product type | Exotic Products |
|---|---|
| Buy / Sell | CALL |
| Underlying | BRISTOL-MYERS SQUIBB COMPANY |
| Issuer | 
Société Générale
|
| WKN | SF3B3P |
| ISIN | DE000SF3B3P3 |
| Date issued | 09/08/2021 |
| Strike | 68.4 $ |
| Maturity | Unlimited |
| Parity | 1 : 1 |
| Emission price | 10.08 € |
| Emission volume | N/A |
| Settlement | cash |
| Currency | EUR |
Technical Indicators
| Highest since issue | 34.42 € |
|---|---|
| Lowest since issue | 0.95 € |
| Spread | 0.1 € |
| Spread % | 0.66% |
Company Profile
Bristol-Myers Squibb Company est spécialisé dans le développement, la fabrication et la commercialisation de produits pharmaceutiques. Les produits sont destinés au traitement des cancers, des maladies cardio-vasculaires, de l'hépatite, des maladies immunitaires et des désordres psychiatriques.
The United States account for 70.1% of net sales.
Sector
-
Ratings for Bristol-Myers Squibb Company
Trading Rating
Investor Rating
ESG Refinitiv
B
Consensus: Bristol-Myers Squibb Company
Sell
Buy
Mean consensus
HOLD
Number of Analysts
26
Last Close Price
41.2
USD
Average target price
53.19
USD
Spread / Average Target
+29.11%
- Stock Market
- Certificates
- Certificat
